These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25917401)
21. Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hundemer GL; Imsirovic H; Vaidya A; Yozamp N; Goupil R; Madore F; Agharazii M; Knoll G; Sood MM Hypertension; 2022 Jan; 79(1):178-186. PubMed ID: 34657442 [TBL] [Abstract][Full Text] [Related]
22. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
23. [The accuracy of combining aldosterone to renin ratio and low renin level in diagnosing primary aldosteronism]. Li F; Xie XY; Zhao TY Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):501-4, 517. PubMed ID: 20629332 [TBL] [Abstract][Full Text] [Related]
24. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests. Ruiz-Sánchez JG; Fernández Sánchez Á; Meneses D Endocrine; 2024 Aug; 85(2):906-915. PubMed ID: 38568364 [TBL] [Abstract][Full Text] [Related]
26. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084 [TBL] [Abstract][Full Text] [Related]
27. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism. Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266 [TBL] [Abstract][Full Text] [Related]
28. Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism. Rye P; Chin A; Pasieka J; So B; Harvey A; Kline G J Clin Hypertens (Greenwich); 2015 Jul; 17(7):541-6. PubMed ID: 25756935 [TBL] [Abstract][Full Text] [Related]
29. Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database. Garcia EA; Lopez JR; Meier JL; Swislocki AL; Siegel D J Clin Hypertens (Greenwich); 2011 Jul; 13(7):487-91. PubMed ID: 21762361 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F Br J Clin Pharmacol; 2018 Nov; 84(11):2535-2543. PubMed ID: 29971815 [TBL] [Abstract][Full Text] [Related]
31. Primary aldosteronism in general practice. Chan NN; Isaacs AJ Lancet; 1999 Mar; 353(9157):1013; author reply 1014. PubMed ID: 10459937 [No Abstract] [Full Text] [Related]
32. Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications. Tomaschitz A; Piecha G; Ritz E; Meinitzer A; Haas J; Pieske B; Wiecek A; Rus-Machan J; Toplak H; März W; Verheyen N; Gaksch M; Amrein K; Kraigher-Krainer E; Fahrleitner-Pammer A; Pilz S Clin Exp Hypertens; 2015; 37(2):108-15. PubMed ID: 24785704 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Nishikawa T; Saito J; Omura M Endocr J; 2007 Aug; 54(4):487-95. PubMed ID: 17124364 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of the post-captopril test in primary aldosteronism. Castro OL; Yu X; Kem DC Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253 [TBL] [Abstract][Full Text] [Related]
35. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391 [TBL] [Abstract][Full Text] [Related]
36. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism]. Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725 [TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan. Sato M; Morimoto R; Seiji K; Iwakura Y; Ono Y; Kudo M; Satoh F; Ito S; Ishibashi T; Takase K Horm Metab Res; 2015 Oct; 47(11):826-32. PubMed ID: 26305168 [TBL] [Abstract][Full Text] [Related]
38. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Hamlet SM; Tunny TJ; Woodland E; Gordon RD Clin Exp Pharmacol Physiol; 1985; 12(3):249-52. PubMed ID: 3896593 [TBL] [Abstract][Full Text] [Related]
39. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism. Koch M; Aker S; Haastert B; Rump LC Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]